CV Sciences, Inc. (CVSI)
OTCMKTS
· Delayed Price · Currency is USD
0.0328
+0.0028 (9.33%)
Jan 14, 2025, 3:31 PM EST
CV Sciences Employees
As of December 31, 2023, CV Sciences had 43 total employees, including 42 full-time and 1 part-time employees. The number of employees decreased by 1 or -2.27% compared to the previous year.
Employees
43
Change (1Y)
-1
Growth (1Y)
-2.27%
Revenue / Employee
$363,302
Profits / Employee
-$59,000
Market Cap
5.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
CV Sciences News
- 7 weeks ago - CV Sciences enters into agreement to acquire Extract Labs - Seeking Alpha
- 7 weeks ago - CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs - PRNewsWire
- 2 months ago - CV Sciences Q3: Revenue Stable Amid New Launches, Financing - Benzinga
- 2 months ago - CV Sciences, Inc. (CVSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CV Sciences Non-GAAP EPS of $0.00, revenue of $3.87M - Seeking Alpha
- 2 months ago - CV Sciences, Inc. Reports Third Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024 - PRNewsWire
- 2 months ago - Marijuana Stock Movers For October 23, 2024 - Benzinga